# Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone/Dapagliflozin

> **NCT07754331** · PHASE1 · RECRUITING · sponsor: **AstraZeneca** · enrollment: 10 (estimated)

## Conditions studied

- Kidney Failure

## Interventions

- **DRUG:** Balcinrenone/dapagliflozin

## Key facts

- **NCT ID:** NCT07754331
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-06
- **Primary completion:** 2026-12-03
- **Final completion:** 2026-12-03
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-09-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07754331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07754331, "Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone/Dapagliflozin". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07754331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*